Helwan University
Clinical trials sponsored by Helwan University, explained in plain language.
-
Common diabetes drug may shield hearts during chemo
Disease control Recruiting nowThis study tests whether dapagliflozin, a drug used for diabetes, can prevent heart damage caused by anthracycline chemotherapy in breast cancer patients. Forty women with breast cancer will take dapagliflozin daily alongside their chemo. Researchers will measure heart function a…
Phase: PHASE4 • Sponsor: Helwan University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New sedation cocktail may protect elderly hearts during ICU breathing support
Symptom relief Recruiting nowThis study compares two sedation methods for elderly ICU patients (65+) who need a breathing tube. One group gets a mix of propofol and ketamine, the other gets propofol alone. The goal is to see which causes fewer dangerous drops in blood pressure. The trial involves 41 particip…
Phase: PHASE3 • Sponsor: Helwan University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New bendable tool could make kidney stone surgery safer
Symptom relief Recruiting nowThis study compares a new bendable tip-suction ureteral access sheath to a standard one during surgery for large kidney stones (staghorn stones). About 100 adults will be randomly assigned to one of the two sheaths. The goal is to see if the new sheath reduces complications and c…
Phase: NA • Sponsor: Helwan University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC